Noteworthy News Regarding Triple-Negative Breast Cancer- Review of cutting-edge developments in the clinical and biological sciences related to triple-negative breast cancer (TNBC) and its treatment, including chemotherapeutic regimens and the pharmacologic rationale for the developments. Discuss implications of these new developments for pharmacists and nurses on patient care and the treatment of patients with TNBC. List future research questions raised by the results of recent clinical trials and other reported developments.
1.0 Contact hour for Nurse Practitioners which inlcudes 1.0 hour of pharmacology
Expires 2/13/12